SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-022527
Filing Date
2022-04-29
Accepted
2022-04-29 08:01:23
Documents
107
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f20f2021_enlivexthera.htm   iXBRL 20-F 1875198
2 SECOND AMENDMENT TO THE CONSULTING AGREEMENT BY AND BETWEEN ENLIVEX THERAPEUTICS f20f2021ex4-25_enlivex.htm EX-4.25 17303
3 LIST OF SUBSIDIARIES OF ENLIVEX THERAPEUTICS LTD. f20f2021ex8-1_enlivex.htm EX-8.1 2986
4 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A)OF THE SE f20f2021ex12-1_enlivex.htm EX-12.1 8091
5 CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A)OF TH f20f2021ex12-2_enlivex.htm EX-12.1 7713
6 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C.1350, FURNISHE f20f2021ex13-1_enlivex.htm EX-13.1 3831
7 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C.1350, FURNISHE f20f2021ex13-2_enlivex.htm EX-13.2 3137
8 CONSENT OF YAREL + PARTNERS f20f2021ex15-1_enlivex.htm EX-15.1 2433
9 GRAPHIC image_001.jpg GRAPHIC 7814
10 GRAPHIC image_002.jpg GRAPHIC 12750
11 GRAPHIC image_003.jpg GRAPHIC 12868
12 GRAPHIC image_004.jpg GRAPHIC 10156
13 GRAPHIC image_005.jpg GRAPHIC 18329
14 GRAPHIC image_006.jpg GRAPHIC 5380
15 GRAPHIC image_007.jpg GRAPHIC 3147
16 GRAPHIC image_008.jpg GRAPHIC 5139
17 GRAPHIC image_009.jpg GRAPHIC 5771
  Complete submission text file 0001213900-22-022527.txt   7604030

Data Files

Seq Description Document Type Size
18 XBRL SCHEMA FILE enlv-20211231.xsd EX-101.SCH 94337
19 XBRL CALCULATION FILE enlv-20211231_cal.xml EX-101.CAL 26540
20 XBRL DEFINITION FILE enlv-20211231_def.xml EX-101.DEF 320810
21 XBRL LABEL FILE enlv-20211231_lab.xml EX-101.LAB 631439
22 XBRL PRESENTATION FILE enlv-20211231_pre.xml EX-101.PRE 337086
101 EXTRACTED XBRL INSTANCE DOCUMENT f20f2021_enlivexthera_htm.xml XML 852016
Mailing Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042
Business Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042 972 (0) 3 7326616
Enlivex Therapeutics Ltd. (Filer) CIK: 0001596812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36578 | Film No.: 22870294
SIC: 2834 Pharmaceutical Preparations